Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00612482 · ClinicalTrials.gov registry record · Phase 1

Youth Substance Use Prevention/Reduction Through Science-based Drug Abuse Education

A Phase 1 study of Substance Abuse, sponsored by Boston Children's Hospital.

Completed
Registry status
Phase 1
Development phase
225
Enrollment target
1
Study location

NCT00612482: Completed Phase 1 study of Substance Abuse, sponsored by Boston Children's Hospital.

NCT00612482 is a Phase 1 study of Substance Abuse that has completed, run by Boston Children's Hospital. The registered enrollment target is 225 participants, below the 5,256-participant average among 58 other Substance Abuse trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00612482, a Phase 1 study of Substance Abuse, has completed, sponsored by Boston Children's Hospital.

COMPLETED
Registry status
Phase 1
Development phase
225 participants
Enrollment target
1
Study location

Study Summary

Our primary goal is to conduct a pilot study of the effects of a new potential strategy for youth substance abuse prevention - science-based drug education integrated into the high school science curriculum. Through this pilot study we propose to: (1) demonstrate that this new strategy shows promise, and (2) estimate the effect size for the intervention.

Conditions Studied

Interventions

  • OTHER drug prevention curriculum

Study Locations (1)

Massachusetts

  • Children's Hospital Boston - Boston

Trial Details

FieldValue
Enrollment Target 225 participants
Start Date 2006-12
Est. Completion 2008-01
Phase Phase 1
Boston Children's Hospital

462 total trials

What the finished NCT00612482 record still lists

NCT00612482 is an interventional study that assigns participants to a tested intervention. The registered 225 participants enrollment target is mid-sized for trials with a published cap, below the 5,256-participant average among 58 other Substance Abuse trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Substance Abuse appearing as the primary indexed condition, and to 1 intervention - of which drug prevention curriculum is the first listed.

NCT00612482 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00612482 about?

NCT00612482 is a clinical study titled "Youth Substance Use Prevention/Reduction Through Science-based Drug Abuse Education". Our primary goal is to conduct a pilot study of the effects of a new potential strategy for youth substance abuse prevention - science-based drug education integrated into the high school science curriculum. Through this pilot study we propose to: (1) demonstrate that this new strategy shows promise...

What is the current status of trial NCT00612482?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 225 participants. The study started on 2006-12. Estimated completion is 2008-01.

What conditions does trial NCT00612482 study?

This clinical trial studies the following conditions: Substance Abuse.

What interventions are being tested in trial NCT00612482?

The interventions under investigation include: drug prevention curriculum (OTHER).

Who is sponsoring clinical trial NCT00612482?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00612482 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Substance Abuse

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00612482's enrollment target sits among peer trials

225 23rd of 58 higher than 36 of 58 other Substance Abuse trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Substance Abuse trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03955445 · 225 participants · Phase 3

    Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN

  • NCT04054310 · 225 participants · NA

    Non-Invasive Quantification of Liver Health in NASH (N-QUAN)

  • NCT04480554 · 225 participants · Phase 2

    Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1

  • NCT04888104 · 225 participants

    Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00612482, the US trial registry maintained by the National Library of Medicine. NCT00612482 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.